Bioniz Therapeutics   Report issue

For profit Phase 2
Founded: Irvine CA United States (2009)
Status: Acquired by Equillium (2022)

Organization Overview

First Clinical Trial
2016
NCT03046459
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Bioniz Therapeutics | Bioniz Therapeutics, Inc.

Active Ingredients

Drugs in Phase 2 Trials (2)

bnz-1 (1 trial)

bnz132-1-40 (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alopecia (Phase 2)

Alopecia Areata (Phase 2)

Leukemia (Phase 2)

Leukemia, Large Granular Lymphocytic (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 2